Published in J Biol Chem on July 24, 1998
Lessons on the pathogenesis of aneurysm from heritable conditions. Nature (2011) 2.97
Suppression of autophagy in skeletal muscle uncovers the accumulation of ubiquitinated proteins and their potential role in muscle damage in Pompe disease. Hum Mol Genet (2008) 2.15
Autophagy and mistargeting of therapeutic enzyme in skeletal muscle in Pompe disease. Mol Ther (2006) 1.88
Enhanced response to enzyme replacement therapy in Pompe disease after the induction of immune tolerance. Am J Hum Genet (2007) 1.76
Neural deficits contribute to respiratory insufficiency in Pompe disease. Proc Natl Acad Sci U S A (2009) 1.67
Role of autophagy in glycogen breakdown and its relevance to chloroquine myopathy. PLoS Biol (2013) 1.59
Immune tolerance induction to enzyme-replacement therapy by co-administration of short-term, low-dose methotrexate in a murine Pompe disease model. Clin Exp Immunol (2008) 1.48
Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proc Natl Acad Sci U S A (1999) 1.46
Transcription factor EB (TFEB) is a new therapeutic target for Pompe disease. EMBO Mol Med (2013) 1.44
Inflammasome up-regulation and activation in dysferlin-deficient skeletal muscle. Am J Pathol (2010) 1.41
Monitoring autophagy in lysosomal storage disorders. Methods Enzymol (2009) 1.40
Pompe disease gene therapy. Hum Mol Genet (2011) 1.39
Suppression of autophagy permits successful enzyme replacement therapy in a lysosomal storage disorder--murine Pompe disease. Autophagy (2010) 1.38
Immunomodulatory gene therapy prevents antibody formation and lethal hypersensitivity reactions in murine pompe disease. Mol Ther (2009) 1.34
Identification and characterization of pharmacological chaperones to correct enzyme deficiencies in lysosomal storage disorders. Assay Drug Dev Technol (2011) 1.28
Carbohydrate-remodelled acid alpha-glucosidase with higher affinity for the cation-independent mannose 6-phosphate receptor demonstrates improved delivery to muscles of Pompe mice. Biochem J (2005) 1.24
Temporal neuropathologic and behavioral phenotype of 6neo/6neo Pompe disease mice. J Neuropathol Exp Neurol (2008) 1.19
Gel-mediated delivery of AAV1 vectors corrects ventilatory function in Pompe mice with established disease. Mol Ther (2010) 1.17
The pharmacological chaperone N-butyldeoxynojirimycin enhances enzyme replacement therapy in Pompe disease fibroblasts. Mol Ther (2009) 1.17
Biochemical and pharmacological characterization of different recombinant acid alpha-glucosidase preparations evaluated for the treatment of Pompe disease. Mol Genet Metab (2008) 1.13
Autophagy and mitochondria in Pompe disease: nothing is so new as what has long been forgotten. Am J Med Genet C Semin Med Genet (2012) 1.10
Hypoglossal neuropathology and respiratory activity in pompe mice. Front Physiol (2011) 1.10
The respiratory neuromuscular system in Pompe disease. Respir Physiol Neurobiol (2013) 1.09
Correction of multiple striated muscles in murine Pompe disease through adeno-associated virus-mediated gene therapy. Mol Ther (2008) 1.09
Pompe disease: from pathophysiology to therapy and back again. Front Aging Neurosci (2014) 1.06
Glycosylation-independent lysosomal targeting of acid α-glucosidase enhances muscle glycogen clearance in pompe mice. J Biol Chem (2012) 1.04
Fiber type conversion by PGC-1α activates lysosomal and autophagosomal biogenesis in both unaffected and Pompe skeletal muscle. PLoS One (2010) 1.03
Detection and imaging of non-contractile inclusions and sarcomeric anomalies in skeletal muscle by second harmonic generation combined with two-photon excited fluorescence. J Struct Biol (2008) 1.02
Enhanced efficacy of enzyme replacement therapy in Pompe disease through mannose-6-phosphate receptor expression in skeletal muscle. Mol Genet Metab (2011) 1.00
Intrapleural administration of AAV9 improves neural and cardiorespiratory function in Pompe disease. Mol Ther (2013) 0.99
Enhanced efficacy of an AAV vector encoding chimeric, highly secreted acid alpha-glucosidase in glycogen storage disease type II. Mol Ther (2006) 0.99
Relationship between glycogen accumulation and the laforin dual specificity phosphatase. Biochem Biophys Res Commun (2006) 0.97
Retrograde gene delivery to hypoglossal motoneurons using adeno-associated virus serotype 9. Hum Gene Ther Methods (2012) 0.95
Animal models for metabolic, neuromuscular and ophthalmological rare diseases. Nat Rev Drug Discov (2013) 0.92
Murine acid alpha-glucosidase: cell-specific mRNA differential expression during development and maturation. Am J Pathol (1999) 0.92
Is genotype determination useful in predicting the clinical phenotype in lysosomal storage diseases? J Inherit Metab Dis (2001) 0.92
Spinal delivery of AAV vector restores enzyme activity and increases ventilation in Pompe mice. Mol Ther (2011) 0.91
Sustained correction of motoneuron histopathology following intramuscular delivery of AAV in pompe mice. Mol Ther (2013) 0.90
Pharmacological enhancement of α-glucosidase by the allosteric chaperone N-acetylcysteine. Mol Ther (2012) 0.89
Stimulation of Respiratory Motor Output and Ventilation in a Murine Model of Pompe Disease by Ampakines. Am J Respir Cell Mol Biol (2015) 0.88
Peripheral nerve and neuromuscular junction pathology in Pompe disease. Hum Mol Genet (2014) 0.87
The value of muscle biopsies in Pompe disease: identifying lipofuscin inclusions in juvenile- and adult-onset patients. Acta Neuropathol Commun (2014) 0.87
Evaluation of systemic follistatin as an adjuvant to stimulate muscle repair and improve motor function in Pompe mice. Mol Ther (2010) 0.87
Mapping the T helper cell response to acid α-glucosidase in Pompe mice. Mol Genet Metab (2012) 0.86
Omigapil treatment decreases fibrosis and improves respiratory rate in dy(2J) mouse model of congenital muscular dystrophy. PLoS One (2013) 0.85
Impaired organization and function of myofilaments in single muscle fibers from a mouse model of Pompe disease. J Appl Physiol (1985) (2010) 0.84
Preclinical toxicology and biodistribution studies of recombinant adeno-associated virus 1 human acid α-glucosidase. Hum Gene Ther Clin Dev (2013) 0.84
Dysregulation of multiple facets of glycogen metabolism in a murine model of Pompe disease. PLoS One (2013) 0.84
Impaired clearance of accumulated lysosomal glycogen in advanced Pompe disease despite high-level vector-mediated transgene expression. J Gene Med (2009) 0.83
Comparative impact of AAV and enzyme replacement therapy on respiratory and cardiac function in adult Pompe mice. Mol Ther Methods Clin Dev (2015) 0.83
A chaperone enhances blood α-glucosidase activity in Pompe disease patients treated with enzyme replacement therapy. Mol Ther (2014) 0.82
Genotype-phenotype correlation in Pompe disease, a step forward. Orphanet J Rare Dis (2014) 0.81
Correcting Neuromuscular Deficits With Gene Therapy in Pompe Disease. Ann Neurol (2015) 0.81
Hydrostatic isolated limb perfusion with adeno-associated virus vectors enhances correction of skeletal muscle in Pompe disease. Gene Ther (2010) 0.81
Non-depleting anti-CD4 monoclonal antibody induces immune tolerance to ERT in a murine model of Pompe disease. Mol Genet Metab Rep (2014) 0.79
Imino sugar glucosidase inhibitors as broadly active anti-filovirus agents. Emerg Microbes Infect (2013) 0.79
Suppression of mTORC1 activation in acid-α-glucosidase-deficient cells and mice is ameliorated by leucine supplementation. Am J Physiol Regul Integr Comp Physiol (2014) 0.78
A Modified Enzymatic Method for Measurement of Glycogen Content in Glycogen Storage Disease Type IV. JIMD Rep (2016) 0.78
Copackaged AAV9 Vectors Promote Simultaneous Immune Tolerance and Phenotypic Correction of Pompe Disease. Hum Gene Ther (2016) 0.78
Starch Binding Domain-containing Protein 1 Plays a Dominant Role in Glycogen Transport to Lysosomes in Liver. J Biol Chem (2016) 0.76
"Get the Balance Right": Pathological Significance of Autophagy Perturbation in Neuromuscular Disorders. J Neuromuscul Dis (2016) 0.76
Neuropathology in respiratory-related motoneurons in young Pompe (Gaa(-/-)) mice. Respir Physiol Neurobiol (2016) 0.75
Identification of Atypical Peri-Nuclear Multivesicular Bodies in Oxidative and Glycolytic Skeletal Muscle of Aged and Pompe's Disease Mouse Models. Front Physiol (2015) 0.75
Modulation of mTOR signaling as a strategy for the treatment of Pompe disease. EMBO Mol Med (2017) 0.75
Production of a functional human acid maltase in tobacco seeds: biochemical analysis, uptake by human GSDII cells, and in vivo studies in GAA knockout mice. Appl Biochem Biotechnol (2013) 0.75
Phosphatidylserine Converts Immunogenic Recombinant Human Acid Alpha-Glucosidase to a Tolerogenic Form in a Mouse Model of Pompe Disease. J Pharm Sci (2016) 0.75
A pilot study on using rapamycin-carrying synthetic vaccine particles (SVP) in conjunction with enzyme replacement therapy to induce immune tolerance in Pompe disease. Mol Genet Metab Rep (2017) 0.75
(13)C/(31)P MRS Metabolic Biomarkers of Disease Progression and Response to AAV Delivery of hGAA in a Mouse Model of Pompe Disease. Mol Ther Methods Clin Dev (2017) 0.75
Airway smooth muscle dysfunction in Pompe (Gaa-/-) mice. Am J Physiol Lung Cell Mol Physiol (2017) 0.75
NOVEL METHOD FOR DETECTION OF GLYCOGEN IN CELLS. Glycobiology (2017) 0.75
The Fork head transcription factor DAF-16 transduces insulin-like metabolic and longevity signals in C. elegans. Nature (1997) 13.09
The Biomolecular Interaction Network Database and related tools 2005 update. Nucleic Acids Res (2005) 12.94
Efficient in vivo manipulation of mouse genomic sequences at the zygote stage. Proc Natl Acad Sci U S A (1996) 12.92
A physical map of the human genome. Nature (2001) 12.39
Cyclopia and defective axial patterning in mice lacking Sonic hedgehog gene function. Nature (1996) 11.46
Intestinal polyposis in mice with a dominant stable mutation of the beta-catenin gene. EMBO J (1999) 10.82
Targeted oncogene activation by site-specific recombination in transgenic mice. Proc Natl Acad Sci U S A (1992) 9.19
Long-term outcome of medical and surgical therapies for gastroesophageal reflux disease: follow-up of a randomized controlled trial. JAMA (2001) 8.40
The structure of the G protein heterotrimer Gi alpha 1 beta 1 gamma 2. Cell (1995) 7.66
Rpe65 is necessary for production of 11-cis-vitamin A in the retinal visual cycle. Nat Genet (1998) 7.57
Methadone maintenance treatment in opiate dependence: a review. BMJ (1994) 7.37
Functional expression of the cre-lox site-specific recombination system in the yeast Saccharomyces cerevisiae. Mol Cell Biol (1987) 5.84
Recombinant human acid [alpha]-glucosidase: major clinical benefits in infantile-onset Pompe disease. Neurology (2006) 5.67
Life without white fat: a transgenic mouse. Genes Dev (1998) 5.08
Normal growth and development in the absence of hepatic insulin-like growth factor I. Proc Natl Acad Sci U S A (1999) 4.84
Smoking initiation by adolescent girls, 1944 through 1988. An association with targeted advertising. JAMA (1994) 4.74
Structures of active conformations of Gi alpha 1 and the mechanism of GTP hydrolysis. Science (1994) 4.43
Action spectrum for melatonin regulation in humans: evidence for a novel circadian photoreceptor. J Neurosci (2001) 4.36
The importin-beta family member Crm1p bridges the interaction between Rev and the nuclear pore complex during nuclear export. Curr Biol (1997) 4.35
Diagnostic risk adjustment for Medicaid: the disability payment system. Health Care Financ Rev (1996) 4.34
Pharmacological and biochemical demonstration of the role of cyclooxygenase 2 in inflammation and pain. Proc Natl Acad Sci U S A (1994) 4.21
Excluding pulmonary embolism at the bedside without diagnostic imaging: management of patients with suspected pulmonary embolism presenting to the emergency department by using a simple clinical model and d-dimer. Ann Intern Med (2001) 4.19
Improving health-based payment for Medicaid beneficiaries: CDPS. Health Care Financ Rev (2000) 3.87
Control of beta-catenin stability: reconstitution of the cytoplasmic steps of the wnt pathway in Xenopus egg extracts. Mol Cell (2000) 3.65
Universal maternal screening for neonatal group B streptococcal disease. Lancet (2000) 3.37
Conserved elements in the 3' untranslated region of flavivirus RNAs and potential cyclization sequences. J Mol Biol (1987) 3.30
Mice that lack thrombospondin 2 display connective tissue abnormalities that are associated with disordered collagen fibrillogenesis, an increased vascular density, and a bleeding diathesis. J Cell Biol (1998) 3.27
Site-specific integration of DNA into wild-type and mutant lox sites placed in the plant genome. Plant J (1995) 3.23
Amphotericin B lipid complex for invasive fungal infections: analysis of safety and efficacy in 556 cases. Clin Infect Dis (1998) 3.09
Changes in population attitudes about where smoking should not be allowed: California versus the rest of the USA. Tob Control (2004) 3.06
The reliability and validity of a scale to measure HIV risk-taking behaviour among intravenous drug users. AIDS (1991) 3.05
Antibiotic-resistant Streptococcus pneumoniae: clinical and epidemiologic aspects. Rev Infect Dis (1981) 2.96
Bacteriophage P1 cre gene and its regulatory region. Evidence for multiple promoters and for regulation by DNA methylation. J Mol Biol (1986) 2.80
Genomic targeting with purified Cre recombinase. Nucleic Acids Res (1993) 2.74
Mater, a maternal effect gene required for early embryonic development in mice. Nat Genet (2000) 2.73
Genomic targeting with a positive-selection lox integration vector allows highly reproducible gene expression in mammalian cells. Proc Natl Acad Sci U S A (1992) 2.72
Variable and tissue-specific hormone resistance in heterotrimeric Gs protein alpha-subunit (Gsalpha) knockout mice is due to tissue-specific imprinting of the gsalpha gene. Proc Natl Acad Sci U S A (1998) 2.71
Lhx2, a LIM homeobox gene, is required for eye, forebrain, and definitive erythrocyte development. Development (1997) 2.66
Substrate recognition by the Cdc20 and Cdh1 components of the anaphase-promoting complex. Genes Dev (2001) 2.66
Tertiary and quaternary structural changes in Gi alpha 1 induced by GTP hydrolysis. Science (1995) 2.64
A novel protein complex that interacts with the vitamin D3 receptor in a ligand-dependent manner and enhances VDR transactivation in a cell-free system. Genes Dev (1998) 2.63
Early onset of inflammation and later involvement of TGFbeta in Duchenne muscular dystrophy. Neurology (2005) 2.53
Reliability of goniometric measurements. Phys Ther (1978) 2.52
Smoking initiation rates in adults and minors: United States, 1944-1988. Am J Epidemiol (1994) 2.52
Clinical significance of nephrotoxicity in patients treated with amphotericin B for suspected or proven aspergillosis. Clin Infect Dis (1999) 2.48
Breast and ovarian cancer incidence after infertility and in vitro fertilisation. Lancet (1995) 2.47
Tuberculosis infection among health care workers in Kampala, Uganda. Int J Tuberc Lung Dis (2005) 2.42
Mortality among industrial workers exposed to formaldehyde. J Natl Cancer Inst (1986) 2.40
Brain stem blood flow, pupillary response, and outcome in patients with severe head injuries. Neurosurgery (1999) 2.35
Calcium-dependent enzyme activation and vacuole formation in the apical granular region of pancreatic acinar cells. Proc Natl Acad Sci U S A (2000) 2.34
Randomized trial of periportal peritoneal bupivacaine for pain relief after laparoscopic cholecystectomy. Br J Surg (1996) 2.33
Dermcidin: a novel human antibiotic peptide secreted by sweat glands. Nat Immunol (2001) 2.29
The occurrence of C-H...O hydrogen bonds in proteins. J Mol Biol (1995) 2.27
A positive selection vector for cloning high molecular weight DNA by the bacteriophage P1 system: improved cloning efficacy. Proc Natl Acad Sci U S A (1992) 2.20
Enzyme replacement therapy in the mouse model of Pompe disease. Mol Genet Metab (2003) 2.17
Use of a fusion protein between GFP and an actin-binding domain to visualize transient filamentous-actin structures. Curr Biol (1998) 2.16
Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A (2000) 2.13
Transesophageal echocardiography in diagnosis of infective endocarditis. Chest (1994) 2.11
Cerebral microsporidiosis due to Encephalitozoon cuniculi in a patient with human immunodeficiency virus infection. N Engl J Med (1997) 2.05
Somatosensory activations during the observation of touch and a case of vision-touch synaesthesia. Brain (2005) 2.04
Comparison of indirect and direct in-situ polymerase chain reaction in cell preparations and tissue sections. Detection of viral DNA, gene rearrangements and chromosomal translocations. Histochemistry (1993) 2.04
Bilateral interpleural block for midline upper abdominal surgery. Can J Anaesth (1991) 2.02
Rat proximal tubule cell line transformed with origin-defective SV40 DNA: autocrine ANG II feedback. Am J Physiol (1999) 2.02
Cranial gunshot wounds. J Am Osteopath Assoc (1990) 2.01
Quality of life for people with dementia living in residential and nursing home care: the impact of performance on activities of daily living, behavioral and psychological symptoms, language skills, and psychotropic drugs. Int Psychogeriatr (2001) 1.96
Development and validation of a multi-dimensional instrument for assessing outcome of treatment among opiate users: the Opiate Treatment Index. Br J Addict (1992) 1.96
Isolation of an antigen of Neisseria gonorrhoeae involved in the human immune response to gonococcal infection. J Bacteriol (1969) 1.95
An enhancer/locus control region is not sufficient to open chromatin. Mol Cell Biol (1993) 1.93
Identification of a calcium channel modulator using a high throughput yeast two-hybrid screen. Nat Biotechnol (1998) 1.92
Clustering of extensive somatic mutations in the variable region of an immunoglobulin heavy chain gene from a human B cell lymphoma. Cell (1986) 1.92
Intravenous safety and pharmacokinetics of a novel dimerizer drug, AP1903, in healthy volunteers. J Clin Pharmacol (2001) 1.91
New York City syndromic surveillance systems. MMWR Morb Mortal Wkly Rep (2004) 1.91
Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1. Cell Death Differ (2005) 1.89
Synthesis and characterization of a model extracellular matrix that induces partial regeneration of adult mammalian skin. Proc Natl Acad Sci U S A (1989) 1.88
Smoking-cessation strategies observed in videotaped general practice consultations. Am J Prev Med (1998) 1.83
The Southwestern Ontario Joint Replacement Pilot Project: electronic point-of-care data collection. Southwestern Ontario Study Group. Can J Surg (2001) 1.82
Site-independent expression of the chicken beta A-globin gene in transgenic mice. Nature (1991) 1.82
Risk-adjusted analysis of surgeon performance: a 1-year study. Br J Surg (1995) 1.81
Surveillance for AIDS-defining opportunistic illnesses, 1992-1997. MMWR CDC Surveill Summ (1999) 1.81
Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1alpha knockout mouse. Mol Cell Biol (1998) 1.81
A bacterial mutation blocking P2 phage late gene expression. Proc Natl Acad Sci U S A (1975) 1.79
Marek disease virus encodes a basic-leucine zipper gene resembling the fos/jun oncogenes that is highly expressed in lymphoblastoid tumors. Proc Natl Acad Sci U S A (1992) 1.78
NKG2D receptors induced by IL-15 costimulate CD28-negative effector CTL in the tissue microenvironment. J Immunol (2001) 1.76
Potent induction of focused Th1-type cellular and humoral immune responses by RTS,S/SBAS2, a recombinant Plasmodium falciparum malaria vaccine. J Infect Dis (1999) 1.76
Paraoxonase status in coronary heart disease: are activity and concentration more important than genotype? Arterioscler Thromb Vasc Biol (2001) 1.76
Morbidity of harvesting of bone grafts from the iliac crest for preprosthetic augmentation procedures: a prospective study. Int J Oral Maxillofac Surg (2004) 1.76
Carrier frequency for glycogen storage disease type II in New York and estimates of affected individuals born with the disease. Am J Med Genet (1998) 1.75
Systematic review of outcomes used to evaluate enhanced recovery after surgery. Br J Surg (2014) 1.74
Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis. Am J Respir Crit Care Med (2001) 1.72
Antigenic relationship of the feline infectious peritonitis virus to coronaviruses of other species. Arch Virol (1978) 1.72
Disruption of the c/ebp alpha gene in adult mouse liver. Mol Cell Biol (1997) 1.72
International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and initial validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology (Oxford) (2003) 1.71
Inhibition of Cdh1-APC by the MAD2-related protein MAD2L2: a novel mechanism for regulating Cdh1. Genes Dev (2001) 1.69
Combined use of clinical assessment and d-dimer to improve the management of patients presenting to the emergency department with suspected deep vein thrombosis (the EDITED Study). J Thromb Haemost (2003) 1.69
Case control study of diffusion tensor imaging in Parkinson's disease. J Neurol Neurosurg Psychiatry (2007) 1.69
Missing data in Likert ratings: A comparison of replacement methods. J Gen Psychol (1998) 1.66